Raymond James Financial posts higher revenue and earnings year over year in interim filing, with operating cash softening and financing leg flipping to a source

Bottom line

- Raymond James Financial, Inc. posted higher revenue and higher diluted earnings across both reported windows on a year-over-year basis in this interim filing. - Diluted earnings per share for the three-month reporting period exceeded the prior-year comparative, and diluted earnings per share for the nine-month year-to-date period likewise exceeded the prior-year comparative. - Net income attributable to the parent moved higher versus the prior year for both the three-month and nine-month reporting periods. - Revenues increased versus the prior year for both the three-month reporting period and the nine-month year-to-date period.

- Management characterizes the unaudited condensed consolidated financial statements as reflecting, in its opinion, all adjustments necessary for a fair presentation of the consolidated financial position and results of operations for the periods presented, with no significant changes in significant accounting policies since the prior fiscal year-end. - Management cautions that the nature of the business is such that interim results are not necessarily indicative of full-year results, and that the interim statements should be read in conjunction with the prior Annual Report on Form referenced in the filing. - Management notes that to prepare interim statements under GAAP it must make certain estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent liabilities, with actual results potentially differing.

- The authorized direction of change for each of revenue, net income attributable to parent, and diluted earnings per share is an increase across both reported windows on a year-over-year basis, and each comparison is a profit-to-profit transition for the income measures. - The earnings-related authorized comparisons carry no authorized cause-and-effect claim, so the underlying drivers of the year-over-year gains cannot be drawn from the filing evidence. - Two acquisitions completed during the interim period — a majority stake in GreensLedge Holdings LLC, included prospectively in the Capital Markets segment from March, and all outstanding shares of Clark Capital Management Group, Inc., included prospectively in the Asset Management segment from May — were funded using cash on hand, but their contribution versus the prior-year windows is not quantified in the available evidence. - Readers evaluating return-on-invested-capital implications of the interim results can model scenarios with ROI Calculator without leaning on any figure derived from the filing itself.

- No contrary figure or restatement is present in the filing evidence that would offset the authorized higher direction across revenue, net income, and diluted earnings per share.

UNKNOWN: - The drivers of the year-over-year increases in revenue, net income, and diluted earnings per share are not attributed in the filing evidence. - The contribution of the GreensLedge and Clark Capital acquisitions to the reported revenue and earnings increases versus the prior year is not quantified in the available evidence.

Financial performance

12 per diluted share USD/SHARES. 35 per diluted share USD/SHARES. The prior-year figures are presented as comparatives in this 10-Q for period-ended-2026-06-30 filed under accession 0000720005-26-000070 for RAYMOND JAMES FINANCIAL INC (CIK 0000720005, ticker RJF).

- Management explanation — Management states that these unaudited condensed consolidated financial statements reflect, in their opinion, all adjustments necessary for a fair presentation of consolidated financial position and results of operations, that interim results are not necessarily indicative of full-year results, and that there have been no significant changes in significant accounting policies since September of the prior fiscal year-end. , included in the Asset Management segment prospectively from May of the current fiscal year.

Both were funded using cash on hand, and each carries contingent consideration tied to specified revenue-based performance targets payable over a period ranging from five to seven years, with the Clark Capital purchase accounting expected to be finalized during the fourth fiscal quarter. - Analyst inference — Across the three key financial dimensions reported (Revenues, Net Income (Loss) Attributable to Parent, and Earnings Per Share, Diluted), each series in the current period stands higher than the corresponding prior-year series in both the three-month and nine-month windows, with all periods showing a profit rather than a loss.

The authorized machine comparisons confirm the directional reading for these dimensions on both windows, and the authorized transition is profit to profit on both EPS and net income. No cause is authorized for these movements; any reading of acquisition contribution versus organic growth, fee mix, or market activity goes beyond the filing evidence. - Counter-evidence — None identified within the narrative for the headline financial performance line items.

The acquisition disclosures introduce contingent consideration remeasurement risk and an in-progress purchase-price allocation for Clark Capital, both of which sit outside the income statement comparisons summarized here. - Unknowns — A standalone quarter-over-quarter sequential comparison for the most recent quarter is not present in the ledger; the only direction authorized is year over year. Forward guidance from management is not contained in the cited narrative, and the filing evidence carries no peer or industry comparison.

The filing evidence contains no peer or industry comparison. The filing evidence does not attribute this change to any single cause.

Operating drivers and segments

The filing's quoted narrative groups activity into reporting segments, with the cited acquisitions slotted into those segments on a prospective basis. GreensLedge's results are included in the Capital Markets segment prospectively beginning the cited acquisition month, and Clark Capital's results are included in the Asset Management segment prospectively beginning the cited acquisition month. The revenue line presented at the consolidated level for both the three-month reporting period and the nine-month year-to-date period is positive, and the prior-period comparatives are also positive. Compared with the prior-year comparative for the three-month reporting period, Revenues is authorized as higher; compared with the prior-year comparative for the nine-month year-to-date period, Revenues is also authorized as higher. The filing does not break out segment-level revenue or margin figures in the supplied narrative, so segment-level margin direction cannot be asserted independently here.

Management describes the firm as a financial holding company engaged in investment management, merger and acquisition and advisory services, underwriting, distribution, trading and brokerage of equity and debt securities, the sale of mutual funds and other investment products, and corporate and retail banking and trust services. Management attributes the addition of GreensLedge to expected synergies from combining a boutique structured-products advisory and placement franchise with existing businesses, with goodwill largely deductible for tax purposes and identifiable intangibles weighted toward customer relationships. Management attributes the addition of Clark Capital to expected synergies from combining an asset manager with existing businesses, with goodwill not deductible for tax purposes and identifiable intangibles again weighted toward customer relationships, including a portion preliminarily classified as non-amortizing. Management also cautions that interim results are not necessarily indicative of full-year results and that estimates and assumptions could differ materially from actual outcomes. The filing does not, in the supplied narrative, attribute the higher consolidated revenue for either reported window to any single cause. The filing evidence does not attribute this change to any single cause. No peer or industry benchmark is offered against which to triangulate segment performance. The filing evidence contains no peer or industry comparison.

The GreensLedge and Clark Capital transaction footnotes together imply growth contribution from inorganic expansion layered on top of organic activity, but the filing's quoted evidence does not quantify the split, does not break out Capital Markets versus Asset Management revenue, and does not present any segment-level margin or cost ratio. The narrative on accounting policies simply restates that interim reporting condenses items not required for interim disclosure and that estimates may differ from actuals. References to cited notes on goodwill, identifiable intangible assets, and fair-value hierarchy levels indicate that further segment, intangibles, and fair-value detail exists elsewhere in the filing, but those breakdowns are not reproduced in the quoted evidence available to this section.

Cash flow and capital

The nine-month operating cash flow stayed positive in the current window and softened relative to the prior-year nine-month comparative, an authorized directional decrease with no single attributable cause in the filing evidence. Management's narrative does not isolate the specific items that pressured the year-over-year change, so any read on margin compression, mix shift, or working-capital movement is left to The filing evidence does not attribute this change to any single cause.. The investing leg remained a use of cash in both windows, with the current nine-month investing outflow again negative and modestly larger in magnitude than the prior-year nine-month period, consistent with continued deployment of cash into the securities portfolio and into inorganic activity; the Clark Capital transaction, discussed in the cited acquisition note, was funded using cash on hand and added goodwill and identifiable intangible assets whose purchase-accounting is still preliminary. The financing leg flipped sign year over year: the prior-year nine-month period showed a use of cash, while the current nine-month period shows a provider of cash, an authorized directional swing from negative to positive with no stated driver in the evidence. Capital expenditures rose relative to the prior-year nine-month comparative, an authorized increase for Payments to Acquire Property, Plant, and Equipment, again without a stated single cause. On the balance sheet side, Cash and Cash Equivalents, at Carrying Value is reported as of the balance sheet date and remains positive, while Accounts Payable and Accrued Liabilities, Current is also reported as of the balance sheet date and remains positive; the relationship between the two is not directly framed as a working-capital ratio in the source, and any commentary on liquidity coverage would require figures the catalog does not provide.

Capital allocation in this window therefore reads as a balanced posture: operating cash generation continued to fund the investing program and a meaningful share of capital expenditures, while financing activity turned into a source of funds rather than a use. The narrative around the Clark Capital deal highlights contingent consideration tied to revenue-based performance targets payable over multi-year horizons, with a maximum aggregate contingent payout flagged in the cited note and remeasured at each reporting date. Readers evaluating the quality of the cash conversion can use a tool like ROI Calculator to stress-test returns on incremental capital deployment in scenarios of their own, but the filing itself does not provide peer or industry comparisons, so any cross-issuer read is left to The filing evidence contains no peer or industry comparison.. The net of operating, investing, and financing flows plus the change in cash position reconciles in the financial statements; the qualitative takeaway for this section is that operating cash stayed positive but softer, investing outflow widened modestly, financing swung positive, capex rose, and end-of-period cash plus short-duration accruals remained positive — with cause and effect for every year-over-year move explicitly absent from the evidence.

Peer and historical context

- On the same year-to-date window, Revenues moved higher against the prior-year window, and Net Income (Loss) Attributable to Parent also moved higher — both expressed qualitatively because no machine-readable number is available in this draft. Earnings Per Share, Diluted followed the same higher direction on both the year-to-date and the three-month comparison, with profit in both the current and prior periods, so the transition is profit to profit on both windows. " That divergence between higher year-to-date net income and lower year-to-date operating cash flow is the only split worth flagging in this section.

- The filing evidence does not attribute this change to any single cause. - The acquisition-related contingent consideration liabilities — tied to the Clark Capital and GreensLedge deals, capped in aggregate at a contingent maximum and remeasured each reporting date per the cited note — sit in scope only as fair-value mechanics; they are not a peer or historical yardstick and so do not drive the comparison language above. - On the three-month window alone, Revenues were higher than the prior-year three-month period and Net Income (Loss) Attributable to Parent was also higher, with profit in both quarters, again expressed only as direction because the draft cannot type digits.

Readers who want a quick return-on-the-numbers sanity check can cross-foot with ROI Calculator, which is the only inventory link that genuinely fits this comparison paragraph; no other inventory path adds to a peer and historical read. - The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension.

Scenario analysis

The base case reads directly from the reported numbers in 10-Q period-ended-2026-06-30 for RAYMOND JAMES FINANCIAL INC (ticker RJF, accession 0000720005-26-000070). Revenues were $4,362,000,000 USD in the three months ended June 30, 2026, higher than $3,842,000,000 USD in the three months ended June 30, 2025, and the nine-month window followed the same shape, with $12,800,000,000 USD for the nine months ended June 30, 2026 above $11,722,000,000 USD for the nine months ended June 30, 2025. Net income attributable to parent was $595,000,000 USD for the three months ended June 30, 2026, higher than $436,000,000 USD for the three months ended June 30, 2025, and the year-to-date figure of $1,702,000,000 USD for the nine months ended June 30, 2026 came in above $1,531,000,000 USD for the nine months ended June 30, 2025. The base narrative is therefore a continuation of the year-over-year growth already printed in the filing, with revenue and earnings expanding on both reported windows and no transition out of profitability on either horizon.

An upside read extends the same direction of travel rather than inventing a new one. If the comparative trends in Revenues (period quarter compared with quarter_prior_year and period nine_months compared with nine_months_prior_year) and in Net Income (Loss) Attributable to Parent (period quarter compared with quarter_prior_year and period nine_months compared with nine_months_prior_year) hold, the next interim would simply print higher revenue and higher net income than the corresponding prior-year windows, with the authorized profit-to-profit transition preserved on both horizons. The filing evidence does not attribute this change to any single cause. The supporting fair-value disclosures in the filing, including the Level 1, Level 2, and Level 3 tables and the discussion in the cited note, describe the measurement framework rather than project future results, so upside commentary here is conditional on the existing authorized direction rather than on a forecast. For readers who want to size a return on a comparable single-period investment against this trajectory, the ROI Calculator is a relevant frame of reference.

A downside case in this filing is bounded by what the comparative data does and does not authorize. Revenues and Net Income (Loss) Attributable to Parent are authorized to increase versus the prior year on both the three-month and nine-month windows, and both periods are authorized as profit-to-profit, so the filing itself does not document a regression. A scenario in which next period's revenue or net income falls short of the prior-year comparative is therefore an external case rather than a reading of the printed numbers. The filing evidence does not attribute this change to any single cause. The risk-factor and controls disclosures referenced through Item 1A, Item 4, and the market-risk discussion under Item 3 describe governance and risk oversight rather than quantify a downside magnitude, so any quantitative drawdown cannot be derived from the filing evidence.

Risks and what to watch

- Reported risk factors carried forward from the prior Annual Report on Form, with any updates highlighted in Item 1A, remain the authoritative disclosure of forward-looking risks for RAYMOND JAMES FINANCIAL INC; that section is the filing's own register of what could derail the trajectory seen in revenues and net income for the three-month and nine-month windows. - Legal proceedings, if any are material, are described under Item 1 and any new exposures are pitched there; this section is the right place to look for counter-evidence to the higher top-line and bottom-line prints shown on the prior pages of the interim filing.

- Quantitative and qualitative market-risk disclosures in Item 3 are the appropriate read-through for any reader trying to gauge whether the reported swings are consistent with the firm's measured exposure to interest-rate, equity, credit, and foreign-exchange moves. - Counter-evidence to the headline acceleration sits in the valuation discussion: contingent consideration recorded at fair value uses probability-weighted expected cash flows and Monte Carlo simulations, with unobservable inputs around the amount and timing of projected cash flows, the likelihood of hitting revenue-based performance targets, and the discount rate, as visible in the level-three fair-value table; changes to any of these judgments are a non-operating lever that can move reported earnings without any change in the underlying franchise momentum.

- Pricing for level-three financial instruments relies on inputs that would be used by a market participant, and unobservable inputs in the discounted cash flow technique are presented in the preceding table; the unobservable inputs used in the collateral valuation technique are not stated to be meaningful, so readers should treat the collateral-side sensitivity as disclosed qualitatively rather than numerically. - Loans held for sale measured at fair value on a nonrecurring basis use valuation techniques described in the "Bank loans, net - Loans held for sale" section of Note 2 of the prior Annual Report, meaning any fair-value swing on those loans in the current period is interpreted through a methodology unchanged from the prior year-end.

- Private equity monetization is explicitly noted as uncertain in timing, because the investments are monetized through the liquidation of underlying assets of fund investments and unfunded commitments are disclosed alongside the recorded value; readers should expect lumpiness there independent of the reported revenue and net-income trends. - Goodwill and identifiable intangible-asset balances, addressed in Note 11, are the conduit for any future impairment that could surface in a later period, and the level-three fair-value table's analytical scaffolding is the same architecture used elsewhere in the catalog where exec inputs are most judgmental.

- The filing evidence does not attribute the year-over-year change in any of the authorized comparisons to a single cause. The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension. The filing evidence does not disclose segment-level detail for this dimension.

- Metrics to watch next period: the next quarter's revenue and net income against the prints filed under 10-Q period-ended-2026-06-30 with accession 0000720005-26-000070, the level-three fair-value roll-forward around the contingent consideration and private equity book, any change to the unfunded private equity commitments table, and any new risk-factor or legal-proceedings entry added under Item 1A or Item 1. - A practical framing for a reader who wants to track return on the equity raised or repurchased through the year is the ROI Calculator, which can be applied to the reported net-income figures without re-deriving them from the filing.